0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Monosialotetrahexosylganglioside Market Insights and Forecast to 2028
Published Date: May 2022
|
Report Code: QYRE-Auto-35G1831
Home | Market Reports | Business & Industrial | Pharmaceuticals & Biotech
Global Monosialotetrahexosylganglioside Market Insights and Forecast to 2028

Global Monosialotetrahexosylganglioside Market Insights and Forecast to 2028

Code: QYRE-Auto-35G1831
Report
May 2022
85 Pages
QYResearch
Region: Global, North America, Europe, Japan, Central & South America,
Description
Table of Content
Tables & Figures
Monosialotetrahexosylganglioside is used to treat patients with central nervous system lesions including brain crest trauma, cerebrovascular accident, and Parkinson's disease.
Market Analysis and Insights: Global Monosialotetrahexosylganglioside Market

The global Monosialotetrahexosylganglioside market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.

Fully considering the economic change by this health crisis, Oral Agents accounting for % of the Monosialotetrahexosylganglioside global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period.

While Brain Crest Trauma segment is altered to an % CAGR throughout this forecast period.
China Monosialotetrahexosylganglioside market size is valued at US$ million in 2021, while the North America and Europe Monosialotetrahexosylganglioside are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period.

As for the Europe Monosialotetrahexosylganglioside landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Monosialotetrahexosylganglioside market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Monosialotetrahexosylganglioside market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Monosialotetrahexosylganglioside market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Monosialotetrahexosylganglioside market.
Global Monosialotetrahexosylganglioside Scope and Market Size
Monosialotetrahexosylganglioside market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Monosialotetrahexosylganglioside market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

Oral Agents
Injection

Segment by Application

Brain Crest Trauma
Cerebrovascular Accident
Parkinson'S Disease

BY COMPANY

Qilu Pharmaceutical
Heilongjiang Harbin Medical University Pharmaceutical
Beijing Sihuan Pharmaceutical
Beijing Saisheng Pharmaceutical
Jilin Yinglian Biopharmaceutical
Southwest Pharmaceutical
Changchun Xiangtong Pharmaceutical

BY REGION

North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Monosialotetrahexosylganglioside Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Oral Agents
1.2.3 Injection
1.3 Market by Application
1.3.1 Global Monosialotetrahexosylganglioside Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Brain Crest Trauma
1.3.3 Cerebrovascular Accident
1.3.4 Parkinson'S Disease
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Monosialotetrahexosylganglioside Market Perspective (2017-2028)
2.2 Monosialotetrahexosylganglioside Growth Trends by Region
2.2.1 Monosialotetrahexosylganglioside Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Monosialotetrahexosylganglioside Historic Market Size by Region (2017-2022)
2.2.3 Monosialotetrahexosylganglioside Forecasted Market Size by Region (2023-2028)
2.3 Monosialotetrahexosylganglioside Market Dynamics
2.3.1 Monosialotetrahexosylganglioside Industry Trends
2.3.2 Monosialotetrahexosylganglioside Market Drivers
2.3.3 Monosialotetrahexosylganglioside Market Challenges
2.3.4 Monosialotetrahexosylganglioside Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Monosialotetrahexosylganglioside Players by Revenue
3.1.1 Global Top Monosialotetrahexosylganglioside Players by Revenue (2017-2022)
3.1.2 Global Monosialotetrahexosylganglioside Revenue Market Share by Players (2017-2022)
3.2 Global Monosialotetrahexosylganglioside Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Monosialotetrahexosylganglioside Revenue
3.4 Global Monosialotetrahexosylganglioside Market Concentration Ratio
3.4.1 Global Monosialotetrahexosylganglioside Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Monosialotetrahexosylganglioside Revenue in 2021
3.5 Monosialotetrahexosylganglioside Key Players Head office and Area Served
3.6 Key Players Monosialotetrahexosylganglioside Product Solution and Service
3.7 Date of Enter into Monosialotetrahexosylganglioside Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Monosialotetrahexosylganglioside Breakdown Data by Type
4.1 Global Monosialotetrahexosylganglioside Historic Market Size by Type (2017-2022)
4.2 Global Monosialotetrahexosylganglioside Forecasted Market Size by Type (2023-2028)
5 Monosialotetrahexosylganglioside Breakdown Data by Application
5.1 Global Monosialotetrahexosylganglioside Historic Market Size by Application (2017-2022)
5.2 Global Monosialotetrahexosylganglioside Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Monosialotetrahexosylganglioside Market Size (2017-2028)
6.2 North America Monosialotetrahexosylganglioside Market Size by Type
6.2.1 North America Monosialotetrahexosylganglioside Market Size by Type (2017-2022)
6.2.2 North America Monosialotetrahexosylganglioside Market Size by Type (2023-2028)
6.2.3 North America Monosialotetrahexosylganglioside Market Share by Type (2017-2028)
6.3 North America Monosialotetrahexosylganglioside Market Size by Application
6.3.1 North America Monosialotetrahexosylganglioside Market Size by Application (2017-2022)
6.3.2 North America Monosialotetrahexosylganglioside Market Size by Application (2023-2028)
6.3.3 North America Monosialotetrahexosylganglioside Market Share by Application (2017-2028)
6.4 North America Monosialotetrahexosylganglioside Market Size by Country
6.4.1 North America Monosialotetrahexosylganglioside Market Size by Country (2017-2022)
6.4.2 North America Monosialotetrahexosylganglioside Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Monosialotetrahexosylganglioside Market Size (2017-2028)
7.2 Europe Monosialotetrahexosylganglioside Market Size by Type
7.2.1 Europe Monosialotetrahexosylganglioside Market Size by Type (2017-2022)
7.2.2 Europe Monosialotetrahexosylganglioside Market Size by Type (2023-2028)
7.2.3 Europe Monosialotetrahexosylganglioside Market Share by Type (2017-2028)
7.3 Europe Monosialotetrahexosylganglioside Market Size by Application
7.3.1 Europe Monosialotetrahexosylganglioside Market Size by Application (2017-2022)
7.3.2 Europe Monosialotetrahexosylganglioside Market Size by Application (2023-2028)
7.3.3 Europe Monosialotetrahexosylganglioside Market Share by Application (2017-2028)
7.4 Europe Monosialotetrahexosylganglioside Market Size by Country
7.4.1 Europe Monosialotetrahexosylganglioside Market Size by Country (2017-2022)
7.4.2 Europe Monosialotetrahexosylganglioside Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Monosialotetrahexosylganglioside Market Size (2017-2028)
8.2 Asia-Pacific Monosialotetrahexosylganglioside Market Size by Type
8.2.1 Asia-Pacific Monosialotetrahexosylganglioside Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Monosialotetrahexosylganglioside Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Monosialotetrahexosylganglioside Market Share by Type (2017-2028)
8.3 Asia-Pacific Monosialotetrahexosylganglioside Market Size by Application
8.3.1 Asia-Pacific Monosialotetrahexosylganglioside Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Monosialotetrahexosylganglioside Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Monosialotetrahexosylganglioside Market Share by Application (2017-2028)
8.4 Asia-Pacific Monosialotetrahexosylganglioside Market Size by Region
8.4.1 Asia-Pacific Monosialotetrahexosylganglioside Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Monosialotetrahexosylganglioside Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Monosialotetrahexosylganglioside Market Size (2017-2028)
9.2 Latin America Monosialotetrahexosylganglioside Market Size by Type
9.2.1 Latin America Monosialotetrahexosylganglioside Market Size by Type (2017-2022)
9.2.2 Latin America Monosialotetrahexosylganglioside Market Size by Type (2023-2028)
9.2.3 Latin America Monosialotetrahexosylganglioside Market Share by Type (2017-2028)
9.3 Latin America Monosialotetrahexosylganglioside Market Size by Application
9.3.1 Latin America Monosialotetrahexosylganglioside Market Size by Application (2017-2022)
9.3.2 Latin America Monosialotetrahexosylganglioside Market Size by Application (2023-2028)
9.3.3 Latin America Monosialotetrahexosylganglioside Market Share by Application (2017-2028)
9.4 Latin America Monosialotetrahexosylganglioside Market Size by Country
9.4.1 Latin America Monosialotetrahexosylganglioside Market Size by Country (2017-2022)
9.4.2 Latin America Monosialotetrahexosylganglioside Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Monosialotetrahexosylganglioside Market Size (2017-2028)
10.2 Middle East & Africa Monosialotetrahexosylganglioside Market Size by Type
10.2.1 Middle East & Africa Monosialotetrahexosylganglioside Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Monosialotetrahexosylganglioside Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Monosialotetrahexosylganglioside Market Share by Type (2017-2028)
10.3 Middle East & Africa Monosialotetrahexosylganglioside Market Size by Application
10.3.1 Middle East & Africa Monosialotetrahexosylganglioside Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Monosialotetrahexosylganglioside Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Monosialotetrahexosylganglioside Market Share by Application (2017-2028)
10.4 Middle East & Africa Monosialotetrahexosylganglioside Market Size by Country
10.4.1 Middle East & Africa Monosialotetrahexosylganglioside Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Monosialotetrahexosylganglioside Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Qilu Pharmaceutical
11.1.1 Qilu Pharmaceutical Company Details
11.1.2 Qilu Pharmaceutical Business Overview
11.1.3 Qilu Pharmaceutical Monosialotetrahexosylganglioside Introduction
11.1.4 Qilu Pharmaceutical Revenue in Monosialotetrahexosylganglioside Business (2017-2022)
11.1.5 Qilu Pharmaceutical Recent Developments
11.2 Heilongjiang Harbin Medical University Pharmaceutical
11.2.1 Heilongjiang Harbin Medical University Pharmaceutical Company Details
11.2.2 Heilongjiang Harbin Medical University Pharmaceutical Business Overview
11.2.3 Heilongjiang Harbin Medical University Pharmaceutical Monosialotetrahexosylganglioside Introduction
11.2.4 Heilongjiang Harbin Medical University Pharmaceutical Revenue in Monosialotetrahexosylganglioside Business (2017-2022)
11.2.5 Heilongjiang Harbin Medical University Pharmaceutical Recent Developments
11.3 Beijing Sihuan Pharmaceutical
11.3.1 Beijing Sihuan Pharmaceutical Company Details
11.3.2 Beijing Sihuan Pharmaceutical Business Overview
11.3.3 Beijing Sihuan Pharmaceutical Monosialotetrahexosylganglioside Introduction
11.3.4 Beijing Sihuan Pharmaceutical Revenue in Monosialotetrahexosylganglioside Business (2017-2022)
11.3.5 Beijing Sihuan Pharmaceutical Recent Developments
11.4 Beijing Saisheng Pharmaceutical
11.4.1 Beijing Saisheng Pharmaceutical Company Details
11.4.2 Beijing Saisheng Pharmaceutical Business Overview
11.4.3 Beijing Saisheng Pharmaceutical Monosialotetrahexosylganglioside Introduction
11.4.4 Beijing Saisheng Pharmaceutical Revenue in Monosialotetrahexosylganglioside Business (2017-2022)
11.4.5 Beijing Saisheng Pharmaceutical Recent Developments
11.5 Jilin Yinglian Biopharmaceutical
11.5.1 Jilin Yinglian Biopharmaceutical Company Details
11.5.2 Jilin Yinglian Biopharmaceutical Business Overview
11.5.3 Jilin Yinglian Biopharmaceutical Monosialotetrahexosylganglioside Introduction
11.5.4 Jilin Yinglian Biopharmaceutical Revenue in Monosialotetrahexosylganglioside Business (2017-2022)
11.5.5 Jilin Yinglian Biopharmaceutical Recent Developments
11.6 Southwest Pharmaceutical
11.6.1 Southwest Pharmaceutical Company Details
11.6.2 Southwest Pharmaceutical Business Overview
11.6.3 Southwest Pharmaceutical Monosialotetrahexosylganglioside Introduction
11.6.4 Southwest Pharmaceutical Revenue in Monosialotetrahexosylganglioside Business (2017-2022)
11.6.5 Southwest Pharmaceutical Recent Developments
11.7 Changchun Xiangtong Pharmaceutical
11.7.1 Changchun Xiangtong Pharmaceutical Company Details
11.7.2 Changchun Xiangtong Pharmaceutical Business Overview
11.7.3 Changchun Xiangtong Pharmaceutical Monosialotetrahexosylganglioside Introduction
11.7.4 Changchun Xiangtong Pharmaceutical Revenue in Monosialotetrahexosylganglioside Business (2017-2022)
11.7.5 Changchun Xiangtong Pharmaceutical Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
    Table 1. Global Monosialotetrahexosylganglioside Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of Oral Agents
    Table 3. Key Players of Injection
    Table 4. Global Monosialotetrahexosylganglioside Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 5. Global Monosialotetrahexosylganglioside Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global Monosialotetrahexosylganglioside Market Size by Region (2017-2022) & (US$ Million)
    Table 7. Global Monosialotetrahexosylganglioside Market Share by Region (2017-2022)
    Table 8. Global Monosialotetrahexosylganglioside Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 9. Global Monosialotetrahexosylganglioside Market Share by Region (2023-2028)
    Table 10. Monosialotetrahexosylganglioside Market Trends
    Table 11. Monosialotetrahexosylganglioside Market Drivers
    Table 12. Monosialotetrahexosylganglioside Market Challenges
    Table 13. Monosialotetrahexosylganglioside Market Restraints
    Table 14. Global Monosialotetrahexosylganglioside Revenue by Players (2017-2022) & (US$ Million)
    Table 15. Global Monosialotetrahexosylganglioside Revenue Share by Players (2017-2022)
    Table 16. Global Top Monosialotetrahexosylganglioside by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Monosialotetrahexosylganglioside as of 2021)
    Table 17. Ranking of Global Top Monosialotetrahexosylganglioside Companies by Revenue (US$ Million) in 2021
    Table 18. Global 5 Largest Players Market Share by Monosialotetrahexosylganglioside Revenue (CR5 and HHI) & (2017-2022)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Monosialotetrahexosylganglioside Product Solution and Service
    Table 21. Date of Enter into Monosialotetrahexosylganglioside Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Monosialotetrahexosylganglioside Market Size by Type (2017-2022) & (US$ Million)
    Table 24. Global Monosialotetrahexosylganglioside Revenue Market Share by Type (2017-2022)
    Table 25. Global Monosialotetrahexosylganglioside Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 26. Global Monosialotetrahexosylganglioside Revenue Market Share by Type (2023-2028)
    Table 27. Global Monosialotetrahexosylganglioside Market Size by Application (2017-2022) & (US$ Million)
    Table 28. Global Monosialotetrahexosylganglioside Revenue Share by Application (2017-2022)
    Table 29. Global Monosialotetrahexosylganglioside Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 30. Global Monosialotetrahexosylganglioside Revenue Share by Application (2023-2028)
    Table 31. North America Monosialotetrahexosylganglioside Market Size by Type (2017-2022) & (US$ Million)
    Table 32. North America Monosialotetrahexosylganglioside Market Size by Type (2023-2028) & (US$ Million)
    Table 33. North America Monosialotetrahexosylganglioside Market Size by Application (2017-2022) & (US$ Million)
    Table 34. North America Monosialotetrahexosylganglioside Market Size by Application (2023-2028) & (US$ Million)
    Table 35. North America Monosialotetrahexosylganglioside Market Size by Country (2017-2022) & (US$ Million)
    Table 36. North America Monosialotetrahexosylganglioside Market Size by Country (2023-2028) & (US$ Million)
    Table 37. Europe Monosialotetrahexosylganglioside Market Size by Type (2017-2022) & (US$ Million)
    Table 38. Europe Monosialotetrahexosylganglioside Market Size by Type (2023-2028) & (US$ Million)
    Table 39. Europe Monosialotetrahexosylganglioside Market Size by Application (2017-2022) & (US$ Million)
    Table 40. Europe Monosialotetrahexosylganglioside Market Size by Application (2023-2028) & (US$ Million)
    Table 41. Europe Monosialotetrahexosylganglioside Market Size by Country (2017-2022) & (US$ Million)
    Table 42. Europe Monosialotetrahexosylganglioside Market Size by Country (2023-2028) & (US$ Million)
    Table 43. Asia Pacific Monosialotetrahexosylganglioside Market Size by Type (2017-2022) & (US$ Million)
    Table 44. Asia Pacific Monosialotetrahexosylganglioside Market Size by Type (2023-2028) & (US$ Million)
    Table 45. Asia Pacific Monosialotetrahexosylganglioside Market Size by Application (2017-2022) & (US$ Million)
    Table 46. Asia Pacific Monosialotetrahexosylganglioside Market Size by Application (2023-2028) & (US$ Million)
    Table 47. Asia Pacific Monosialotetrahexosylganglioside Market Size by Region (2017-2022) & (US$ Million)
    Table 48. Asia Pacific Monosialotetrahexosylganglioside Market Size by Region (2023-2028) & (US$ Million)
    Table 49. Latin America Monosialotetrahexosylganglioside Market Size by Type (2017-2022) & (US$ Million)
    Table 50. Latin America Monosialotetrahexosylganglioside Market Size by Type (2023-2028) & (US$ Million)
    Table 51. Latin America Monosialotetrahexosylganglioside Market Size by Application (2017-2022) & (US$ Million)
    Table 52. Latin America Monosialotetrahexosylganglioside Market Size by Application (2023-2028) & (US$ Million)
    Table 53. Latin America Monosialotetrahexosylganglioside Market Size by Country (2017-2022) & (US$ Million)
    Table 54. Latin America Monosialotetrahexosylganglioside Market Size by Country (2023-2028) & (US$ Million)
    Table 55. Middle East and Africa Monosialotetrahexosylganglioside Market Size by Type (2017-2022) & (US$ Million)
    Table 56. Middle East and Africa Monosialotetrahexosylganglioside Market Size by Type (2023-2028) & (US$ Million)
    Table 57. Middle East and Africa Monosialotetrahexosylganglioside Market Size by Application (2017-2022) & (US$ Million)
    Table 58. Middle East and Africa Monosialotetrahexosylganglioside Market Size by Application (2023-2028) & (US$ Million)
    Table 59. Middle East and Africa Monosialotetrahexosylganglioside Market Size by Country (2017-2022) & (US$ Million)
    Table 60. Middle East and Africa Monosialotetrahexosylganglioside Market Size by Country (2023-2028) & (US$ Million)
    Table 61. Qilu Pharmaceutical Company Details
    Table 62. Qilu Pharmaceutical Business Overview
    Table 63. Qilu Pharmaceutical Monosialotetrahexosylganglioside Product
    Table 64. Qilu Pharmaceutical Revenue in Monosialotetrahexosylganglioside Business (2017-2022) & (US$ Million)
    Table 65. Qilu Pharmaceutical Recent Developments
    Table 66. Heilongjiang Harbin Medical University Pharmaceutical Company Details
    Table 67. Heilongjiang Harbin Medical University Pharmaceutical Business Overview
    Table 68. Heilongjiang Harbin Medical University Pharmaceutical Monosialotetrahexosylganglioside Product
    Table 69. Heilongjiang Harbin Medical University Pharmaceutical Revenue in Monosialotetrahexosylganglioside Business (2017-2022) & (US$ Million)
    Table 70. Heilongjiang Harbin Medical University Pharmaceutical Recent Developments
    Table 71. Beijing Sihuan Pharmaceutical Company Details
    Table 72. Beijing Sihuan Pharmaceutical Business Overview
    Table 73. Beijing Sihuan Pharmaceutical Monosialotetrahexosylganglioside Product
    Table 74. Beijing Sihuan Pharmaceutical Revenue in Monosialotetrahexosylganglioside Business (2017-2022) & (US$ Million)
    Table 75. Beijing Sihuan Pharmaceutical Recent Developments
    Table 76. Beijing Saisheng Pharmaceutical Company Details
    Table 77. Beijing Saisheng Pharmaceutical Business Overview
    Table 78. Beijing Saisheng Pharmaceutical Monosialotetrahexosylganglioside Product
    Table 79. Beijing Saisheng Pharmaceutical Revenue in Monosialotetrahexosylganglioside Business (2017-2022) & (US$ Million)
    Table 80. Beijing Saisheng Pharmaceutical Recent Developments
    Table 81. Jilin Yinglian Biopharmaceutical Company Details
    Table 82. Jilin Yinglian Biopharmaceutical Business Overview
    Table 83. Jilin Yinglian Biopharmaceutical Monosialotetrahexosylganglioside Product
    Table 84. Jilin Yinglian Biopharmaceutical Revenue in Monosialotetrahexosylganglioside Business (2017-2022) & (US$ Million)
    Table 85. Jilin Yinglian Biopharmaceutical Recent Developments
    Table 86. Southwest Pharmaceutical Company Details
    Table 87. Southwest Pharmaceutical Business Overview
    Table 88. Southwest Pharmaceutical Monosialotetrahexosylganglioside Product
    Table 89. Southwest Pharmaceutical Revenue in Monosialotetrahexosylganglioside Business (2017-2022) & (US$ Million)
    Table 90. Southwest Pharmaceutical Recent Developments
    Table 91. Changchun Xiangtong Pharmaceutical Company Details
    Table 92. Changchun Xiangtong Pharmaceutical Business Overview
    Table 93. Changchun Xiangtong Pharmaceutical Monosialotetrahexosylganglioside Product
    Table 94. Changchun Xiangtong Pharmaceutical Revenue in Monosialotetrahexosylganglioside Business (2017-2022) & (US$ Million)
    Table 95. Changchun Xiangtong Pharmaceutical Recent Developments
    Table 96. Research Programs/Design for This Report
    Table 97. Key Data Information from Secondary Sources
    Table 98. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Monosialotetrahexosylganglioside Market Share by Type: 2021 VS 2028
    Figure 2. Oral Agents Features
    Figure 3. Injection Features
    Figure 4. Global Monosialotetrahexosylganglioside Market Share by Application: 2021 VS 2028
    Figure 5. Brain Crest Trauma Case Studies
    Figure 6. Cerebrovascular Accident Case Studies
    Figure 7. Parkinson'S Disease Case Studies
    Figure 8. Monosialotetrahexosylganglioside Report Years Considered
    Figure 9. Global Monosialotetrahexosylganglioside Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 10. Global Monosialotetrahexosylganglioside Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 11. Global Monosialotetrahexosylganglioside Market Share by Region: 2021 VS 2028
    Figure 12. Global Monosialotetrahexosylganglioside Market Share by Players in 2021
    Figure 13. Global Top Monosialotetrahexosylganglioside Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Monosialotetrahexosylganglioside as of 2021)
    Figure 14. The Top 10 and 5 Players Market Share by Monosialotetrahexosylganglioside Revenue in 2021
    Figure 15. North America Monosialotetrahexosylganglioside Market Size YoY (2017-2028) & (US$ Million)
    Figure 16. North America Monosialotetrahexosylganglioside Market Size Market Share by Type (2017-2028)
    Figure 17. North America Monosialotetrahexosylganglioside Market Size Market Share by Application (2017-2028)
    Figure 18. North America Monosialotetrahexosylganglioside Market Size Share by Country (2017-2028)
    Figure 19. United States Monosialotetrahexosylganglioside Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Canada Monosialotetrahexosylganglioside Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Europe Monosialotetrahexosylganglioside Market Size YoY (2017-2028) & (US$ Million)
    Figure 22. Europe Monosialotetrahexosylganglioside Market Size Market Share by Type (2017-2028)
    Figure 23. Europe Monosialotetrahexosylganglioside Market Size Market Share by Application (2017-2028)
    Figure 24. Europe Monosialotetrahexosylganglioside Market Size Share by Country (2017-2028)
    Figure 25. Germany Monosialotetrahexosylganglioside Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. France Monosialotetrahexosylganglioside Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. U.K. Monosialotetrahexosylganglioside Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Italy Monosialotetrahexosylganglioside Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Russia Monosialotetrahexosylganglioside Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Nordic Countries Monosialotetrahexosylganglioside Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Asia-Pacific Monosialotetrahexosylganglioside Market Size YoY (2017-2028) & (US$ Million)
    Figure 32. Asia Pacific Monosialotetrahexosylganglioside Market Size Market Share by Type (2017-2028)
    Figure 33. Asia Pacific Monosialotetrahexosylganglioside Market Size Market Share by Application (2017-2028)
    Figure 34. Asia Pacific Monosialotetrahexosylganglioside Market Size Share by Region (2017-2028)
    Figure 35. China Monosialotetrahexosylganglioside Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Japan Monosialotetrahexosylganglioside Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. South Korea Monosialotetrahexosylganglioside Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Southeast Asia Monosialotetrahexosylganglioside Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. India Monosialotetrahexosylganglioside Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Australia Monosialotetrahexosylganglioside Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
    Figure 41. Latin America Monosialotetrahexosylganglioside Market Size YoY (2017-2028) & (US$ Million)
    Figure 42. Latin America Monosialotetrahexosylganglioside Market Size Market Share by Type (2017-2028)
    Figure 43. Latin America Monosialotetrahexosylganglioside Market Size Market Share by Application (2017-2028)
    Figure 44. Latin America Monosialotetrahexosylganglioside Market Size Share by Country (2017-2028)
    Figure 45. Mexico Monosialotetrahexosylganglioside Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 46. Brazil Monosialotetrahexosylganglioside Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 47. Middle East & Africa Monosialotetrahexosylganglioside Market Size YoY (2017-2028) & (US$ Million)
    Figure 48. Middle East and Africa Monosialotetrahexosylganglioside Market Size Market Share by Type (2017-2028)
    Figure 49. Middle East and Africa Monosialotetrahexosylganglioside Market Size Market Share by Application (2017-2028)
    Figure 50. Middle East and Africa Monosialotetrahexosylganglioside Market Size Share by Country (2017-2028)
    Figure 51. Turkey Monosialotetrahexosylganglioside Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 52. Saudi Arabia Monosialotetrahexosylganglioside Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 53. UAE Monosialotetrahexosylganglioside Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 54. Qilu Pharmaceutical Revenue Growth Rate in Monosialotetrahexosylganglioside Business (2017-2022)
    Figure 55. Heilongjiang Harbin Medical University Pharmaceutical Revenue Growth Rate in Monosialotetrahexosylganglioside Business (2017-2022)
    Figure 56. Beijing Sihuan Pharmaceutical Revenue Growth Rate in Monosialotetrahexosylganglioside Business (2017-2022)
    Figure 57. Beijing Saisheng Pharmaceutical Revenue Growth Rate in Monosialotetrahexosylganglioside Business (2017-2022)
    Figure 58. Jilin Yinglian Biopharmaceutical Revenue Growth Rate in Monosialotetrahexosylganglioside Business (2017-2022)
    Figure 59. Southwest Pharmaceutical Revenue Growth Rate in Monosialotetrahexosylganglioside Business (2017-2022)
    Figure 60. Changchun Xiangtong Pharmaceutical Revenue Growth Rate in Monosialotetrahexosylganglioside Business (2017-2022)
    Figure 61. Bottom-up and Top-down Approaches for This Report
    Figure 62. Data Triangulation
    Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart

Electronic (PDF)
$4900
This license allows only one user(purchaser of the report) to access the PDF.

Electronic (PDF)
$7350
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Electronic (PDF)
$9800
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Lukasiewicz Research Network

RELATED REPORTS

Global and United States Biologics Drug Development Market Report Forecast 2022 2028
Global and United States Biologics Drug Development Market Report & Forecast 2022-2028

120 Pages
Type: Report
Code: QYRE-Auto-5X6010
Tue Jun 07 00:00:00 UTC 2022

Add to Cart

Global and United States Biologics Drug Discovery Market Report Forecast 2022 2028
Global and United States Biologics Drug Discovery Market Report & Forecast 2022-2028

120 Pages
Type: Report
Code: QYRE-Auto-0D6239
Tue Jun 07 00:00:00 UTC 2022

Add to Cart

Global and United States Nanopharmaceutical Drugs Market Report Forecast 2022 2028
Global and United States Nanopharmaceutical Drugs Market Report & Forecast 2022-2028

The increasing prevalence of chronic diseases and development of the healthcare infrastructure are promoting the adoption of the novel medicine known as nanomedicine for better efficacy and improved patient outcome.Market Analysis and Insights Global and United States Nanopharmaceutical Drugs MarketThis report focuses on global and United States Nanopharmaceutical Drugs market also covers the segmentation data of other regions in regional level and county level.Due to the COVID19 pandemic the global Nanopharmaceutical Drugs market size is estimated to be worth US 35330 million in 2022 and is forecast to a readjusted size of US 72540 million by 2028 with a CAGR of 12.7 during the review period.

120 Pages
Type: Report
Code: QYRE-Auto-24J10248
Tue Jun 07 00:00:00 UTC 2022

Add to Cart

Global and United States Polymerase Chain Reaction Technology Market Report Forecast 2022 2028
Global and United States Polymerase Chain Reaction Technology Market Report & Forecast 2022-2028

120 Pages
Type: Report
Code: QYRE-Auto-7I6111
Tue Jun 07 00:00:00 UTC 2022

Add to Cart